Progress in Diabetes Technology: Developments in Insulin Pumps, Continuous Glucose Monitors, and Progress towards the Artificial Pancreas

Journal of Pediatrics

Volumn 169, Issue , 2016, Pages 13-20

  Forlenza, Gregory P ^a   Buckingham, Bruce ^b   Maahs, David M ^a  

^a UNIVERSITY OF COLORADO DENVER   (United States)

^b STANFORD UNIVERSITY   (United States)

Author keywords

CGM Continuous glucose monitoring; CSII Continuous insulin infusion; DKA Diabetic ketoacidosis; HbA1c Hemoglobin A1c; JDRF Juvenile Diabetes Research Foundation; MDI Multiple daily injection; MPC Model predictive control; PID Proportional integral derivative; SAP Sensor augmented pump; T1D Type 1 diabetes

Indexed keywords

HEMOGLOBIN A1C; INSULIN; PARACETAMOL;

ARTICLE; ARTIFICIAL PANCREAS; BLOOD GLUCOSE METER; BLOOD GLUCOSE MONITORING; BODY IMAGE; CELL TRANSPLANTATION; DIABETIC KETOACIDOSIS; DIABETIC NEPHROPATHY; DIABETIC NEUROPATHY; DIABETIC RETINOPATHY; DRUG DELIVERY DEVICE; GLUCOSE BLOOD LEVEL; GLUCOSE SENSOR; GLYCEMIC CONTROL; HUMAN; HYPERGLYCEMIA; HYPOGLYCEMIA; IMMUNOMODULATION; INSULIN DEPENDENT DIABETES MELLITUS; INSULIN PUMP; PREVALENCE; PRIORITY JOURNAL; SELF CARE; SENSOR; CHILD; DIABETES MELLITUS; INSULIN INFUSION; INVENTION;

BLOOD GLUCOSE SELF-MONITORING; CHILD; DIABETES MELLITUS; HUMANS; INSULIN INFUSION SYSTEMS; INVENTIONS; PANCREAS, ARTIFICIAL;

EID: 84959371016     PISSN: 00223476     EISSN: 10976833     Source Type: Journal    
DOI: 10.1016/j.jpeds.2015.10.015     Document Type: Article

References (94)

1. D.J. Pettitt, J. Talton, D. Dabelea, J. Divers, G. Imperatore, J.M. Lawrence, and et al. Prevalence of diabetes in U.S. youth in 2009: the SEARCH for diabetes in youth study Diabetes Care 37 2014 402 408
2. G.P. Forlenza, and M. Rewers The epidemic of type 1 diabetes: what is it telling us? Curr Opin Endocrinol Diabetes Obes 18 2011 248 251
3. The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. The Diabetes Control and Complications Trial Research Group N Engl J Med 329 1993 977 986
4. S. James, R. Gallagher, J. Dunbabin, and L. Perry Prevalence of vascular complications and factors predictive of their development in young adults with type 1 diabetes: systematic literature review BMC Res Notes 7 2014 593
5. D.M. Maahs, S.R. Daniels, S.D. de Ferranti, H.L. Dichek, J. Flynn, B.I. Goldstein, and et al. Cardiovascular disease risk factors in youth with diabetes mellitus: a scientific statement from the american heart association Circulation 130 2014 1532 1558
6. K.M. Miller, N.C. Foster, R.W. Beck, R.M. Bergenstal, S.N. DuBose, L.A. DiMeglio, and et al. Current state of type 1 diabetes treatment in the U.S.: updated data from the T1D Exchange Clinic Registry Diabetes Care 38 2015 971 978
7. W.V. Tamborlane, R.S. Sherwin, M. Genel, and P. Felig Reduction to normal of plasma glucose in juvenile diabetes by subcutaneous administration of insulin with a portable infusion pump N Engl J Med 300 1979 573 578
8. P.E. Cryer Mechanisms of hypoglycemia-associated autonomic failure in diabetes N Engl J Med 369 2013 362 372
9. F.R. Kaufman, M. Halvorson, D. Miller, M. Mackenzie, L.K. Fisher, and P. Pitukcheewanont Insulin pump therapy in type 1 pediatric patients: now and into the year 2000 Diabetes Metab Res Rev 15 1999 338 352
10. M. Shichiri, Y. Yamasaki, K. Nao, M. Sekiya, and N. Ueda In vivo characteristics of needle-type glucose sensor-measurements of subcutaneous glucose concentrations in human volunteers Horm Metab Res Suppl 20 1988 17 20
11. E.F. Pfeiffer The glucose sensor: the missing link in diabetes therapy Horm Metab Res Suppl 24 1990 154 164
12. U. Fischer Continuous in vivo monitoring in diabetes: the subcutaneous glucose concentration Acta Anaesthesiol Scand Suppl 104 1995 21 29
13. B.H. Ginsbergh The FDA panel advised approval of the first continuous glucose sensor Diabetes Technol Ther 1 1999 203 204
14. K. Rebrin, G.M. Steil, W.P. van Antwerp, and J.J. Mastrototaro Subcutaneous glucose predicts plasma glucose independent of insulin: implications for continuous monitoring Am J Physiol 277 1999 E561 E571
15. K. Rebrin, U. Fischer, H. Hahn von Dorsche, T. Von Woetke, P. Abel, and E. Brunstein Subcutaneous glucose monitoring by means of electrochemical sensors: fiction or reality J Biomed Eng 14 1992 33 40
16. T. Berhe, D. Postellon, B. Wilson, and R. Stone Feasibility and safety of insulin pump therapy in children aged 2 to 7 years with type 1 diabetes: a retrospective study Pediatrics 117 2006 2132 2137
17. R. Nimri, N. Weintrob, H. Benzaquen, R. Ofan, G. Fayman, and M. Phillip Insulin pump therapy in youth with type 1 diabetes: a retrospective paired study Pediatrics 117 2006 2126 2131
18. R. Retnakaran, J. Hochman, J.H. DeVries, H. Hanaire-Broutin, R.J. Heine, V. Melki, and et al. Continuous subcutaneous insulin infusion versus multiple daily injections: the impact of baseline A1c Diabetes Care 27 2004 2590 2596
19. J. Weissberg-Benchell, J. Antisdel-Lomaglio, and R. Seshadri Insulin pump therapy: a meta-analysis Diabetes Care 26 2003 1079 1087
20. L.A. DiMeglio, T.M. Pottorff, S.R. Boyd, L. France, N. Fineberg, and E.A. Eugster A randomized, controlled study of insulin pump therapy in diabetic preschoolers J Pediatr 145 2004 380 384
21. L.A. Fox, L.M. Buckloh, S.D. Smith, T. Wysocki, and N. Mauras A randomized controlled trial of insulin pump therapy in young children with type 1 diabetes Diabetes Care 28 2005 1277 1281
22. Z.M. Nabhan, N.C. Kreher, D.M. Greene, E.A. Eugster, W. Kronenberger, and L.A. DiMeglio A randomized prospective study of insulin pump vs. insulin injection therapy in very young children with type 1 diabetes: 12-month glycemic, BMI, and neurocognitive outcomes Pediatr Diabetes 10 2009 202 208
23. D.M. Maahs, S.E. Hofer, N.C. Foster, J.M. Hermann, W.V. Tamborlane, T.M. Kapellen, and et al. Insulin pump use in pediatric type 1 diabetes: multinational comparison with 54,768 pediatric patients from the T1D exchange (US), national paediatric diabetes audit (England and Wales), and the DPV initiative (Germany and Austria) [abstract] Pediatr Diabetes 15 2014 47
24. B.S. Steindel, T.R. Roe, G. Costin, M. Carlson, and F.R. Kaufman Continuous subcutaneous insulin infusion (CSII) in children and adolescents with chronic poorly controlled type 1 diabetes mellitus Diabetes Res Clin Pract 27 1995 199 204
25. Pozzilli P, Battelino T, Danne T, Hovorka R, Jarosz-Chobot P, Renard E. Continuous subcutaneous insulin infusion in diabetes: patient populations, safety, efficacy, and pharmacoeconomics. Diabetes Metab Res Rev 2015 Apr 13. http://dx.doi.org/10.1002/dmrr.2653. [Epub ahead of print]
26. C. Mameli, A.E. Scaramuzza, J. Ho, R. Cardona-Hernandez, L. Suarez-Ortega, and G.V. Zuccotti A 7-year follow-up retrospective, international, multicenter study of insulin pump therapy in children and adolescents with type 1 diabetes Acta Diabetol 51 2014 205 210
27. F.M. Alsaleh, F.J. Smith, and K.M. Taylor Experiences of children/young people and their parents, using insulin pump therapy for the management of type 1 diabetes: qualitative review J Clin Pharm Ther 37 2012 140 147
28. M.D. Ritholz, A. Smaldone, J. Lee, A. Castillo, H. Wolpert, and K. Weinger Perceptions of psychosocial factors and the insulin pump Diabetes Care 30 2007 549 554
29. R.M. Bergenstal, W.V. Tamborlane, A. Ahmann, J.B. Buse, G. Dailey, S.N. Davis, and et al. Effectiveness of sensor-augmented insulin-pump therapy in type 1 diabetes N Engl J Med 363 2010 311 320
30. Juvenile Diabetes Research Foundation Continuous Glucose Monitoring Study Group W.V. Tamborlane, R.W. Beck, B.W. Bode, B. Buckingham, H.P. Chase, and et al. Continuous glucose monitoring and intensive treatment of type 1 diabetes N Engl J Med 359 2008 1464 1476
31. R.W. Beck, B. Buckingham, K. Miller, H. Wolpert, D. Xing, J.M. Block, and et al. Factors predictive of use and of benefit from continuous glucose monitoring in type 1 diabetes Diabetes Care 32 2009 1947 1953
32. Effectiveness of continuous glucose monitoring in a clinical care environment: evidence from the Juvenile Diabetes Research Foundation continuous glucose monitoring (JDRF-CGM) trial Diabetes Care 33 2010 17 22
33. H.P. Chase, R.W. Beck, D. Xing, W.V. Tamborlane, J. Coffey, L.A. Fox, and et al. Continuous glucose monitoring in youth with type 1 diabetes: 12-month follow-up of the Juvenile Diabetes Research Foundation continuous glucose monitoring randomized trial Diabetes Technol Ther 12 2010 507 515
34. J.C. Wong, N.C. Foster, D.M. Maahs, D. Raghinaru, R.M. Bergenstal, A.J. Ahmann, and et al. Real-time continuous glucose monitoring among participants in the T1D Exchange clinic registry Diabetes Care 37 2014 2702 2709
35. W.H. Polonsky, and D. Hessler What are the quality of life-related benefits and losses associated with real-time continuous glucose monitoring? A survey of current users Diabetes Technol Ther 15 2013 295 301
36. K.D. Barnard, T. Wysocki, H. Thabit, M.L. Evans, S. Amiel, S. Heller, and et al. Psychosocial aspects of closed- and open-loop insulin delivery: closing the loop in adults with Type 1 diabetes in the home setting Diabet Med 32 2015 601 608
37. Abbott. Newsroom: Abbott Receives CE Mark for FreeStyle® Libre, a Revolutionary Glucose Monitoring System for People with Diabetes. https://www.abbottdiabetescare.com/press-room/2014.html. Accessed October 15, 2015.
38. Sparling K. CGM in the Cloud: the how, why, and why not of remote CGM watching. http://diatribe.org/companiesorganization/nightscout#sthash.m9rNhBia.dpuf. Accessed October 15, 2015.
39. N. Baysal, F. Cameron, B.A. Buckingham, D.M. Wilson, H.P. Chase, D.M. Maahs, and et al. A novel method to detect pressure-induced sensor attenuations (PISA) in an artificial pancreas J Diabetes Sci Technol 8 2014 1091 1096
40. D.M. Maahs, D. DeSalvo, L. Pyle, T. Ly, L. Messer, P. Clinton, and et al. Effect of acetaminophen on CGM glucose in an outpatient setting Diabetes Care 38 2015 e158 e159
41. R.A. Vigersky The benefits, limitations, and cost-effectiveness of advanced technologies in the management of patients with diabetes mellitus J Diabetes Sci Technol 9 2015 320 330
42. S. Roze, R. Saunders, A. Brandt, S. de Portu, N.L. Papo, and J. Jendle Health-economic analysis of real-time continuous glucose monitoring in people with Type 1 diabetes Diabet Med 32 2015 618 626
43. E.S. Huang, M. O'Grady, A. Basu, A. Winn, P. John, J. Lee, and et al. The cost-effectiveness of continuous glucose monitoring in type 1 diabetes Diabetes Care 33 2010 1269 1274
44. Juvenile Diabetes Research Foundation. Artificial Pancreas Project Research; 2006. http://jdrf.org/research/treat/artificial-pancreas-project/. Accessed March 25, 2015.
45. A.J. Kowalski Can we really close the loop and how soon? Accelerating the availability of an artificial pancreas: a roadmap to better diabetes outcomes Diabetes Technol Ther 11 Suppl 1 2009 S113 S119
46. T.T. Ly, J.A. Nicholas, A. Retterath, E.M. Lim, E.A. Davis, and T.W. Jones Effect of sensor-augmented insulin pump therapy and automated insulin suspension vs standard insulin pump therapy on hypoglycemia in patients with type 1 diabetes: a randomized clinical trial JAMA 310 2013 1240 1247
47. R.M. Bergenstal, D.C. Klonoff, S.K. Garg, B.W. Bode, M. Meredith, R.H. Slover, and et al. Threshold-based insulin-pump interruption for reduction of hypoglycemia N Engl J Med 369 2013 224 232
48. D.M. Maahs, P. Calhoun, B.A. Buckingham, H.P. Chase, I. Hramiak, J. Lum, and et al. A randomized trial of a home system to reduce nocturnal hypoglycemia in type 1 diabetes Diabetes Care 37 2014 1885 1891
49. B.A. Buckingham, F. Cameron, P. Calhoun, D.M. Maahs, D.M. Wilson, H.P. Chase, and et al. Outpatient safety assessment of an in-home predictive low-glucose suspend system with type 1 diabetes subjects at elevated risk of nocturnal hypoglycemia Diabetes Technol Ther 15 2013 622 627
50. B.P. Kovatchev, E. Renard, C. Cobelli, H.C. Zisser, P. Keith-Hynes, S.M. Anderson, and et al. Safety of outpatient closed-loop control: first randomized crossover trials of a wearable artificial pancreas Diabetes Care 37 2014 1789 1796
51. L. Leelarathna, S. Dellweg, J.K. Mader, J.M. Allen, C. Benesch, W. Doll, and et al. Day and night home closed-loop insulin delivery in adults with type 1 diabetes: three-center randomized crossover study Diabetes Care 37 2014 1931 1937
52. S.A. Weinzimer, G.M. Steil, K.L. Swan, J. Dziura, N. Kurtz, and W.V. Tamborlane Fully automated closed-loop insulin delivery versus semiautomated hybrid control in pediatric patients with type 1 diabetes using an artificial pancreas Diabetes Care 31 2008 934 939
53. M. Phillip, T. Battelino, E. Atlas, O. Kordonouri, N. Bratina, S. Miller, and et al. Nocturnal glucose control with an artificial pancreas at a diabetes camp N Engl J Med 368 2013 824 833
54. S.J. Russell, F.H. El-Khatib, M. Sinha, K.L. Magyar, K. McKeon, L.G. Goergen, and et al. Outpatient glycemic control with a bionic pancreas in type 1 diabetes N Engl J Med 371 2014 313 325
55. A. Kowalski Pathway to artificial pancreas systems revisited: moving downstream Diabetes Care 38 2015 1036 1043
56. S. Beck Guidance for industry and food and drug administration staff: The content of investigational device exemption (IDE) and premarket approval (PMA) applications for artificial pancreas device systems [Internet] 2012 U.S. Department of Health and Human Services; Food and Drug Administration; Center for Devices and Radiological Health Rockville (MD)
57. P. Agrawal, A. Zhong, J.B. Welsh, R. Shah, and F.R. Kaufman Retrospective analysis of the real-world use of the threshold suspend feature of sensor-augmented insulin pumps Diabetes Technol Ther 17 2015 316 319
58. B.A. Buckingham, D. Raghinaru, F. Cameron, B.W. Bequette, H.P. Chase, D.M. Maahs, and et al. Predictive low-glucose insulin suspension reduces duration of nocturnal hypoglycemia in children without increasing ketosis Diabetes Care 38 2015 1197 1204
59. D.A. Finan, T.W. McCann Jr., L. Mackowiak, E. Dassau, S.D. Patek, B.P. Kovatchev, and et al. Closed-Loop Control Performance of the Hypoglycemia-Hyperglycemia Minimizer (HHM) System in a Feasibility Study J Diabetes Sci Technol 8 2014 35 42
60. T.T. Ly, A. Roy, B. Grosman, J. Shin, A. Campbell, S. Monirabbasi, and et al. Day and Night Closed-Loop Control Using the Integrated Medtronic Hybrid Closed-Loop System in Type 1 Diabetes at Diabetes Camp Diabetes Care 38 2015 1205 1211
61. T.T. Ly, M.D. Breton, P. Keith-Hynes, D. De Salvo, P. Clinton, K. Benassi, and et al. Overnight glucose control with an automated, unified safety system in children and adolescents with type 1 diabetes at diabetes camp Diabetes Care 37 2014 2310 2316
62. K.J. Astrom, and R.M. Murray Feedback systems: An introduction for scientists and engineers 2008 Princeton University Press Princeton, NJ
63. B.W. Bequette Algorithms for a closed-loop artificial pancreas: the case for model predictive control J Diabetes Sci Technol 7 2013 1632 1643
64. F.J. Doyle III, L.M. Huyett, J.B. Lee, H.C. Zisser, and E. Dassau Closed-loop artificial pancreas systems: engineering the algorithms Diabetes Care 37 2014 1191 1197
65. G.M. Steil, K. Rebrin, C. Darwin, F. Hariri, and M.F. Saad Feasibility of automating insulin delivery for the treatment of type 1 diabetes Diabetes 55 2006 3344 3350
66. R. Hovorka, V. Canonico, L.J. Chassin, U. Haueter, M. Massi-Benedetti, M. Orsini Federici, and et al. Nonlinear model predictive control of glucose concentration in subjects with type 1 diabetes Physiol Meas 25 2004 905 920
67. W.L. Clarke, S. Anderson, M. Breton, S. Patek, L. Kashmer, and B. Kovatchev Closed-loop artificial pancreas using subcutaneous glucose sensing and insulin delivery and a model predictive control algorithm: the Virginia experience J Diabetes Sci Technol 3 2009 1031 1038
68. R. Nimri, and M. Phillip Artificial pancreas: fuzzy logic and control of glycemia Curr Opin Endocrinol Diabetes Obes 21 2014 251 256
69. R. Mauseth, Y. Wang, E. Dassau, R. Kircher Jr., D. Matheson, H. Zisser, and et al. Proposed clinical application for tuning fuzzy logic controller of artificial pancreas utilizing a personalization factor J Diabetes Sci Technol 4 2010 913 922
70. R. Mauseth, I.B. Hirsch, J. Bollyky, R. Kircher, D. Matheson, S. Sanda, and et al. Use of a "fuzzy logic" controller in a closed-loop artificial pancreas Diabetes Technol Ther 15 2013 628 633
71. diaTribe K. Close, and A. Brown Bigfoot Biomedical Sets its Sights on Simplifying Type 1 Diabetes Management http://diatribe.org/bigfoot-biomedical-sets-its-sights-simplifying-type-1-diabetes-management 2015 Accessed October 15, 2015
72. B. Carson They hacked her pancreas and found love along the way http://www.businessinsider.com/hacked-raspberry-pi-artificial-pancreas-2015-8?utm-source=gatehouse&utm-medium=referral&utm-content=feed 2015 Accessed October 15, 2015
73. V.N. Shah, A. Shoskes, B. Tawfik, and S.K. Garg Closed-loop system in the management of diabetes: past, present, and future Diabetes Technol Ther 16 2014 477 490
74. M. Breton, A. Farret, D. Bruttomesso, S. Anderson, L. Magni, S. Patek, and et al. Fully integrated artificial pancreas in type 1 diabetes: modular closed-loop glucose control maintains near normoglycemia Diabetes 61 2012 2230 2237
75. F. Cameron, G. Niemeyer, D.M. Wilson, B.W. Bequette, K.S. Benassi, P. Clinton, and et al. Inpatient trial of an artificial pancreas based on multiple model probabilistic predictive control with repeated large unannounced meals Diabetes Technol Ther 16 2014 728 734
76. H.P. Chase, F.J. Doyle III, H. Zisser, E. Renard, R. Nimri, C. Cobelli, and et al. Multicenter closed-loop/hybrid meal bolus insulin delivery with type 1 diabetes Diabetes Technol Ther 16 2014 623 632
77. D. Elleri, J.M. Allen, M. Biagioni, K. Kumareswaran, L. Leelarathna, K. Caldwell, and et al. Evaluation of a portable ambulatory prototype for automated overnight closed-loop insulin delivery in young people with type 1 diabetes Pediatr Diabetes 13 2012 449 453
78. D. Elleri, J.M. Allen, K. Kumareswaran, L. Leelarathna, M. Nodale, K. Caldwell, and et al. Closed-loop basal insulin delivery over 36 hours in adolescents with type 1 diabetes: randomized clinical trial Diabetes Care 36 2013 838 844
79. H. Zisser, E. Renard, B. Kovatchev, C. Cobelli, A. Avogaro, R. Nimri, and et al. Multicenter closed-loop insulin delivery study points to challenges for keeping blood glucose in a safe range by a control algorithm in adults and adolescents with type 1 diabetes from various sites Diabetes Technol Ther 16 2014 613 622
80. S.A. Brown, B.P. Kovatchev, M.D. Breton, S.M. Anderson, P. Keith-Hynes, S.D. Patek, and et al. Multinight "bedside" closed-loop control for patients with type 1 diabetes Diabetes Technol Ther 17 2015 203 209
81. H. Thabit, D. Elleri, L. Leelarathna, J.M. Allen, A. Lubina-Solomon, M. Stadler, and et al. Unsupervised home use of an overnight closed-loop system over 3-4 weeks: a pooled analysis of randomized controlled studies in adults and adolescents with type 1 diabetes Diabetes Obes Metab 17 2015 452 458
82. M.J. O'Grady, A.J. Retterath, D.B. Keenan, N. Kurtz, M. Cantwell, G. Spital, and et al. The use of an automated, portable glucose control system for overnight glucose control in adolescents and young adults with type 1 diabetes Diabetes Care 35 2012 2182 2187
83. R. Nimri, I. Muller, E. Atlas, S. Miller, A. Fogel, N. Bratina, and et al. MD-Logic overnight control for 6 weeks of home use in patients with type 1 diabetes: randomized crossover trial Diabetes Care 37 2014 3025 3032
84. F.H. El-Khatib, J. Jiang, and E.R. Damiano Adaptive closed-loop control provides blood-glucose regulation using dual subcutaneous insulin and glucagon infusion in diabetic Swine J Diabetes Sci Technol 1 2007 181 192
85. P.G. Jacobs, J. El Youssef, J. Castle, P. Bakhtiani, D. Branigan, M. Breen, and et al. Automated control of an adaptive bihormonal, dual-sensor artificial pancreas and evaluation during inpatient studies IEEE Trans Biomed Eng 61 2014 2569 2581
86. A.T. Sands, B.P. Zambrowicz, J. Rosenstock, P. Lapuerta, B.W. Bode, S.K. Garg, and et al. Sotagliflozin, a dual SGLT1 and SGLT2 inhibitor, as adjunct therapy to insulin in type 1 diabetes Diabetes Care 38 2015 1181 1188
87. A.N. Traina, M.E. Lull, A.C. Hui, T.M. Zahorian, and J. Lyons-Patterson Once-weekly exenatide as adjunct treatment of type 1 diabetes mellitus in patients receiving continuous subcutaneous insulin infusion therapy Can J Diabetes 38 2014 269 272
88. V.S. Renukuntla, N. Ramchandani, J. Trast, M. Cantwell, and R.A. Heptulla Role of glucagon-like peptide-1 analogue versus amylin as an adjuvant therapy in type 1 diabetes in a closed loop setting with ePID algorithm J Diabetes Sci Technol 8 2014 1011 1017
89. B.A. Perkins, D.Z. Cherney, H. Partridge, N. Soleymanlou, H. Tschirhart, B. Zinman, and et al. Sodium-glucose cotransporter 2 inhibition and glycemic control in type 1 diabetes: results of an 8-week open-label proof-of-concept trial Diabetes Care 37 2014 1480 1483
90. H. Zisser, E. Dassau, J.J. Lee, R.A. Harvey, W. Bevier, and F.J. Doyle III Clinical results of an automated artificial pancreas using technosphere inhaled insulin to mimic first-phase insulin secretion J Diabetes Sci Technol 9 2015 564 572
91. P.A. Bakhtiani, N. Caputo, J.R. Castle, J. El Youssef, J.M. Carroll, L.L. David, and et al. A novel, stable, aqueous glucagon formulation using ferulic acid as an excipient J Diabetes Sci Technol 9 2015 17 23
92. B. Newswanger, S. Ammons, N. Phadnis, W.K. Ward, J. Castle, R.W. Campbell, and et al. Development of a highly stable, nonaqueous glucagon formulation for delivery via infusion pump systems J Diabetes Sci Technol 9 2015 24 33
93. R.W. Beck Downloading diabetes device data: empowering patients to download at home to achieve better outcomes Diabetes Technol Ther 17 2015 536 537
94. M.J. O'Grady, P. John, and A. Winn Substantial Medicare savings may result if insurers cover 'artificial pancreas' sooner for diabetes patients Health Affairs (Project Hope) 31 2012 1822 1829